Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Opiate Dependence
Interventions
DRUG

Extended-Release Naltrexone

380mg IM XR-NTX injection one week prior to release from jail; a second XR-NTX 380mg IM injection is offered 4 weeks later (monthly).

BEHAVIORAL

Motivational Enhancement Counseling

The randomized control arm receives no medication treatment and is offered brief, two-session Motivational Enhancement counseling prior to release from jail.

Trial Locations (2)

10016

New York University School of Medicine, New York

11370

New York City Department of Correction, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Alkermes, Inc.

INDUSTRY

collaborator

New York City Department of Health and Mental Hygiene

OTHER_GOV

lead

NYU Langone Health

OTHER